Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial
Premium

Bond Baba: Is Unichem Buyback Worth a Peck?

capital-mind-premium-featured-image.png

Unichem - A specialty pharmaceutical company, specialized in niche therapy areas of cardiology, neurology, orthopedics and anti-infective. Unichem has recently concluded its sale of domestic business (including Nepal business including Sikkim) to Torrent Pharma. While the deal was finalized for Rs 3,600 Cr, Unichem came out with buyback offer to enhance the shareholders value post sale . . .

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial